ID   DPOG2_HUMAN             Reviewed;         485 AA.
AC   Q9UHN1; O00419; Q0IJ81; Q96GW2; Q9UK35; Q9UK94;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 152.
DE   RecName: Full=DNA polymerase subunit gamma-2, mitochondrial;
DE            EC=2.7.7.7;
DE   AltName: Full=DNA polymerase gamma accessory 55 kDa subunit;
DE            Short=p55;
DE   AltName: Full=Mitochondrial DNA polymerase accessory subunit;
DE   AltName: Full=MtPolB;
DE   AltName: Full=PolG-beta;
DE   Flags: Precursor;
GN   Name=POLG2; Synonyms=MTPOLB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=10608893; DOI=10.1074/jbc.274.53.38197;
RA   Lim S.E., Longley M.J., Copeland W.C.;
RT   "The mitochondrial p55 accessory subunit of human DNA polymerase gamma
RT   enhances DNA binding, promotes processive DNA synthesis, and confers
RT   N-ethylmaleimide resistance.";
RL   J. Biol. Chem. 274:38197-38203(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-169.
RX   PubMed=10666468; DOI=10.1093/nar/28.5.1237;
RA   Carrodeguas J.A., Bogenhagen D.F.;
RT   "Protein sequences conserved in prokaryotic aminoacyl-tRNA synthetases
RT   are important for the activity of the processivity factor of human
RT   mitochondrial DNA polymerase.";
RL   Nucleic Acids Res. 28:1237-1244(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10677218; DOI=10.1021/bi992104w;
RA   Johnson A.A., Tsai Y.-C., Graves S.W., Johnson K.A.;
RT   "Human mitochondrial DNA polymerase holoenzyme: reconstitution and
RT   characterization.";
RL   Biochemistry 39:1702-1708(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS THR-169 AND
RP   ALA-416.
RC   TISSUE=Cervix, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 114-485.
RX   PubMed=9153213; DOI=10.1074/jbc.272.21.13640;
RA   Wang Y., Farr C.L., Kaguni L.S.;
RT   "Accessory subunit of mitochondrial DNA polymerase from Drosophila
RT   embryos. Cloning, molecular analysis, and association in the native
RT   enzyme.";
RL   J. Biol. Chem. 272:13640-13646(1997).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8]
RP   VARIANT PEOA4 GLU-451, AND CHARACTERIZATION OF VARIANT PEOA4 GLU-451.
RX   PubMed=16685652; DOI=10.1086/504303;
RA   Longley M.J., Clark S., Man C.Y.W., Hudson G., Durham S.E.,
RA   Taylor R.W., Nightingale S., Turnbull D.M., Copeland W.C.,
RA   Chinnery P.F.;
RT   "Mutant POLG2 disrupts DNA polymerase gamma subunits and causes
RT   progressive external ophthalmoplegia.";
RL   Am. J. Hum. Genet. 78:1026-1034(2006).
RN   [9]
RP   VARIANT ALA-416, AND CHARACTERIZATION OF VARIANT ALA-416.
RX   PubMed=18195150; DOI=10.1001/archneurol.2007.9;
RA   Ferraris S., Clark S., Garelli E., Davidzon G., Moore S.A.,
RA   Kardon R.H., Bienstock R.J., Longley M.J., Mancuso M.,
RA   Gutierrez Rios P., Hirano M., Copeland W.C., DiMauro S.;
RT   "Progressive external ophthalmoplegia and vision and hearing loss in a
RT   patient with mutations in POLG2 and OPA1.";
RL   Arch. Neurol. 65:125-131(2008).
CC   -!- FUNCTION: Mitochondrial polymerase processivity subunit.
CC       Stimulates the polymerase and exonuclease activities, and
CC       increases the processivity of the enzyme. Binds to ss-DNA.
CC   -!- CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) =
CC       diphosphate + DNA(n+1).
CC   -!- SUBUNIT: Heterotrimer composed of a catalytic subunit and a
CC       homodimer of accessory subunits.
CC   -!- INTERACTION:
CC       P54098:POLG; NbExp=10; IntAct=EBI-852642, EBI-852624;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial
CC       DNA deletions, autosomal dominant, 4 (PEOA4) [MIM:610131]: A
CC       disorder characterized by progressive weakness of ocular muscles
CC       and levator muscle of the upper eyelid. In a minority of cases, it
CC       is associated with skeletal myopathy, which predominantly involves
CC       axial or proximal muscles and which causes abnormal fatigability
CC       and even permanent muscle weakness. Ragged-red fibers and atrophy
CC       are found on muscle biopsy. A large proportion of chronic
CC       ophthalmoplegias are associated with other symptoms, leading to a
CC       multisystemic pattern of this disease. Additional symptoms are
CC       variable, and may include cataracts, hearing loss, sensory axonal
CC       neuropathy, ataxia, depression, hypogonadism, and parkinsonism.
CC       {ECO:0000269|PubMed:16685652}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF142992; AAD50382.1; -; mRNA.
DR   EMBL; AF177201; AAD56640.1; -; mRNA.
DR   EMBL; AF184344; AAD56542.1; -; mRNA.
DR   EMBL; BC000913; AAH00913.2; -; mRNA.
DR   EMBL; BC009194; AAH09194.1; -; mRNA.
DR   EMBL; U94703; AAC51321.1; -; mRNA.
DR   CCDS; CCDS32706.1; -.
DR   RefSeq; NP_009146.2; NM_007215.3.
DR   UniGene; Hs.437009; -.
DR   PDB; 2G4C; X-ray; 3.15 A; A/B/C/D=26-485.
DR   PDB; 3IKL; X-ray; 3.10 A; A/B=1-146, A/B=181-485.
DR   PDB; 3IKM; X-ray; 3.24 A; B/C/E/F=59-485.
DR   PDB; 4ZTU; X-ray; 3.30 A; B/C=26-485.
DR   PDB; 4ZTZ; X-ray; 3.44 A; B/C=26-485.
DR   PDB; 5C51; X-ray; 3.43 A; B/C=1-485.
DR   PDB; 5C52; X-ray; 3.64 A; B/C=1-485.
DR   PDB; 5C53; X-ray; 3.57 A; B/C=1-485.
DR   PDBsum; 2G4C; -.
DR   PDBsum; 3IKL; -.
DR   PDBsum; 3IKM; -.
DR   PDBsum; 4ZTU; -.
DR   PDBsum; 4ZTZ; -.
DR   PDBsum; 5C51; -.
DR   PDBsum; 5C52; -.
DR   PDBsum; 5C53; -.
DR   ProteinModelPortal; Q9UHN1; -.
DR   SMR; Q9UHN1; -.
DR   BioGrid; 116398; 14.
DR   IntAct; Q9UHN1; 8.
DR   STRING; 9606.ENSP00000442563; -.
DR   iPTMnet; Q9UHN1; -.
DR   PhosphoSitePlus; Q9UHN1; -.
DR   BioMuta; POLG2; -.
DR   DMDM; 17367139; -.
DR   EPD; Q9UHN1; -.
DR   MaxQB; Q9UHN1; -.
DR   PaxDb; Q9UHN1; -.
DR   PeptideAtlas; Q9UHN1; -.
DR   PRIDE; Q9UHN1; -.
DR   Ensembl; ENST00000539111; ENSP00000442563; ENSG00000256525.
DR   GeneID; 11232; -.
DR   KEGG; hsa:11232; -.
DR   UCSC; uc002jei.4; human.
DR   CTD; 11232; -.
DR   DisGeNET; 11232; -.
DR   GeneCards; POLG2; -.
DR   HGNC; HGNC:9180; POLG2.
DR   HPA; CAB017030; -.
DR   HPA; HPA023202; -.
DR   MalaCards; POLG2; -.
DR   MIM; 604983; gene.
DR   MIM; 610131; phenotype.
DR   neXtProt; NX_Q9UHN1; -.
DR   OpenTargets; ENSG00000256525; -.
DR   Orphanet; 254892; Autosomal dominant progressive external ophthalmoplegia.
DR   PharmGKB; PA33501; -.
DR   eggNOG; KOG2298; Eukaryota.
DR   eggNOG; COG0423; LUCA.
DR   GeneTree; ENSGT00390000000244; -.
DR   HOGENOM; HOG000049133; -.
DR   HOVERGEN; HBG051401; -.
DR   InParanoid; Q9UHN1; -.
DR   KO; K02333; -.
DR   OMA; LYYNFPW; -.
DR   OrthoDB; EOG091G0B28; -.
DR   PhylomeDB; Q9UHN1; -.
DR   TreeFam; TF103005; -.
DR   BRENDA; 2.7.7.7; 2681.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   ChiTaRS; POLG2; human.
DR   EvolutionaryTrace; Q9UHN1; -.
DR   GeneWiki; POLG2; -.
DR   GenomeRNAi; 11232; -.
DR   PRO; PR:Q9UHN1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000256525; -.
DR   CleanEx; HS_POLG2; -.
DR   ExpressionAtlas; Q9UHN1; baseline and differential.
DR   Genevisible; Q9UHN1; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0000262; C:mitochondrial chromosome; TAS:ProtInc.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; TAS:ProtInc.
DR   GO; GO:0004820; F:glycine-tRNA ligase activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0006281; P:DNA repair; NAS:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; NAS:UniProtKB.
DR   GO; GO:0006261; P:DNA-dependent DNA replication; TAS:ProtInc.
DR   GO; GO:0006426; P:glycyl-tRNA aminoacylation; IBA:GO_Central.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0032042; P:mitochondrial DNA metabolic process; IEA:Ensembl.
DR   GO; GO:0070584; P:mitochondrion morphogenesis; IEA:Ensembl.
DR   GO; GO:0007005; P:mitochondrion organization; TAS:Reactome.
DR   GO; GO:0022904; P:respiratory electron transport chain; IEA:Ensembl.
DR   Gene3D; 3.40.50.800; -; 1.
DR   InterPro; IPR004154; Anticodon-bd.
DR   InterPro; IPR027031; Gly-tRNA_synthase/POLG2.
DR   InterPro; IPR027030; POLG2.
DR   PANTHER; PTHR10745; PTHR10745; 1.
DR   PANTHER; PTHR10745:SF9; PTHR10745:SF9; 1.
DR   Pfam; PF03129; HGTP_anticodon; 1.
DR   SUPFAM; SSF52954; SSF52954; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disease mutation; DNA replication;
KW   DNA-binding; DNA-directed DNA polymerase; Mitochondrion;
KW   Nucleotidyltransferase; Phosphoprotein;
KW   Progressive external ophthalmoplegia; Reference proteome; Transferase;
KW   Transit peptide.
FT   TRANSIT       1      ?       Mitochondrion. {ECO:0000255}.
FT   CHAIN         ?    485       DNA polymerase subunit gamma-2,
FT                                mitochondrial.
FT                                /FTId=PRO_0000007314.
FT   MOD_RES      38     38       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     169    169       A -> T (in dbSNP:rs1427463).
FT                                {ECO:0000269|PubMed:10666468,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032028.
FT   VARIANT     416    416       G -> A (there is no functional deficit;
FT                                dbSNP:rs17850455).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18195150}.
FT                                /FTId=VAR_032029.
FT   VARIANT     451    451       G -> E (in PEOA4; affects stimulation of
FT                                the catalytic subunit;
FT                                dbSNP:rs104894632).
FT                                {ECO:0000269|PubMed:16685652}.
FT                                /FTId=VAR_029364.
FT   CONFLICT    114    124       WWTSVVVFREQ -> MVDLGGGVHGA (in Ref. 5;
FT                                AAC51321). {ECO:0000305}.
FT   CONFLICT    122    122       R -> T (in Ref. 3; AAD56542).
FT                                {ECO:0000305}.
FT   CONFLICT    136    136       G -> S (in Ref. 3; AAD56542 and 5;
FT                                AAC51321). {ECO:0000305}.
FT   CONFLICT    287    292       NKLYYN -> TNFTTI (in Ref. 5; AAC51321).
FT                                {ECO:0000305}.
FT   HELIX        60     66       {ECO:0000244|PDB:3IKM}.
FT   HELIX        69     75       {ECO:0000244|PDB:3IKL}.
FT   STRAND       78     80       {ECO:0000244|PDB:3IKM}.
FT   TURN         83     86       {ECO:0000244|PDB:3IKL}.
FT   HELIX        88     92       {ECO:0000244|PDB:3IKL}.
FT   HELIX       101    118       {ECO:0000244|PDB:3IKL}.
FT   TURN        119    122       {ECO:0000244|PDB:2G4C}.
FT   STRAND      125    127       {ECO:0000244|PDB:2G4C}.
FT   STRAND      132    134       {ECO:0000244|PDB:2G4C}.
FT   TURN        135    137       {ECO:0000244|PDB:3IKM}.
FT   STRAND      138    141       {ECO:0000244|PDB:3IKM}.
FT   STRAND      146    149       {ECO:0000244|PDB:2G4C}.
FT   HELIX       150    153       {ECO:0000244|PDB:2G4C}.
FT   HELIX       154    156       {ECO:0000244|PDB:2G4C}.
FT   STRAND      157    159       {ECO:0000244|PDB:2G4C}.
FT   TURN        161    165       {ECO:0000244|PDB:2G4C}.
FT   HELIX       166    168       {ECO:0000244|PDB:2G4C}.
FT   HELIX       171    177       {ECO:0000244|PDB:2G4C}.
FT   STRAND      179    181       {ECO:0000244|PDB:2G4C}.
FT   HELIX       186    192       {ECO:0000244|PDB:3IKL}.
FT   TURN        193    197       {ECO:0000244|PDB:3IKL}.
FT   HELIX       198    200       {ECO:0000244|PDB:3IKL}.
FT   STRAND      203    215       {ECO:0000244|PDB:3IKL}.
FT   STRAND      224    226       {ECO:0000244|PDB:3IKM}.
FT   STRAND      233    243       {ECO:0000244|PDB:3IKL}.
FT   HELIX       245    247       {ECO:0000244|PDB:3IKL}.
FT   HELIX       248    266       {ECO:0000244|PDB:3IKL}.
FT   HELIX       270    272       {ECO:0000244|PDB:3IKL}.
FT   STRAND      273    278       {ECO:0000244|PDB:3IKL}.
FT   STRAND      281    284       {ECO:0000244|PDB:3IKL}.
FT   STRAND      286    292       {ECO:0000244|PDB:3IKL}.
FT   STRAND      297    305       {ECO:0000244|PDB:3IKL}.
FT   HELIX       309    314       {ECO:0000244|PDB:3IKL}.
FT   STRAND      319    322       {ECO:0000244|PDB:3IKL}.
FT   STRAND      325    328       {ECO:0000244|PDB:3IKL}.
FT   STRAND      334    341       {ECO:0000244|PDB:3IKL}.
FT   HELIX       342    351       {ECO:0000244|PDB:3IKL}.
FT   TURN        359    361       {ECO:0000244|PDB:3IKM}.
FT   STRAND      362    364       {ECO:0000244|PDB:3IKM}.
FT   TURN        376    378       {ECO:0000244|PDB:3IKL}.
FT   STRAND      379    381       {ECO:0000244|PDB:3IKM}.
FT   STRAND      383    389       {ECO:0000244|PDB:3IKL}.
FT   HELIX       395    408       {ECO:0000244|PDB:3IKL}.
FT   STRAND      413    415       {ECO:0000244|PDB:2G4C}.
FT   HELIX       416    418       {ECO:0000244|PDB:3IKL}.
FT   STRAND      419    421       {ECO:0000244|PDB:3IKL}.
FT   HELIX       426    432       {ECO:0000244|PDB:3IKL}.
FT   HELIX       433    435       {ECO:0000244|PDB:3IKL}.
FT   STRAND      438    443       {ECO:0000244|PDB:3IKL}.
FT   HELIX       445    448       {ECO:0000244|PDB:2G4C}.
FT   STRAND      450    457       {ECO:0000244|PDB:3IKL}.
FT   TURN        458    460       {ECO:0000244|PDB:3IKL}.
FT   STRAND      464    467       {ECO:0000244|PDB:3IKM}.
FT   HELIX       470    484       {ECO:0000244|PDB:3IKL}.
SQ   SEQUENCE   485 AA;  54911 MW;  B99734BFEA249192 CRC64;
     MRSRVAVRAC HKVCRCLLSG FGGRVDAGQP ELLTERSSPK GGHVKSHAEL EGNGEHPEAP
     GSGEGSEALL EICQRRHFLS GSKQQLSRDS LLSGCHPGFG PLGVELRKNL AAEWWTSVVV
     FREQVFPVDA LHHKPGPLLP GDSAFRLVSA ETLREILQDK ELSKEQLVAF LENVLKTSGK
     LRENLLHGAL EHYVNCLDLV NKRLPYGLAQ IGVCFHPVFD TKQIRNGVKS IGEKTEASLV
     WFTPPRTSNQ WLDFWLRHRL QWWRKFAMSP SNFSSSDCQD EEGRKGNKLY YNFPWGKELI
     ETLWNLGDHE LLHMYPGNVS KLHGRDGRKN VVPCVLSVNG DLDRGMLAYL YDSFQLTENS
     FTRKKNLHRK VLKLHPCLAP IKVALDVGRG PTLELRQVCQ GLFNELLENG ISVWPGYLET
     MQSSLEQLYS KYDEMSILFT VLVTETTLEN GLIHLRSRDT TMKEMMHISK LKDFLIKYIS
     SAKNV
//
